Overview
- NB.1.8.1 accounts for about 10.7% of global Covid infections and has been detected in at least 22 countries.
- The UK Health Security Agency has confirmed 13 cases in England and is closely tracking the variant’s domestic spread.
- Research indicates NB.1.8.1 may transmit more efficiently than earlier strains due to key spike protein mutations.
- Current Covid-19 vaccines are expected to remain effective against NB.1.8.1 and health authorities are promoting booster programmes for eligible groups.
- Reduced routine testing may understate NB.1.8.1’s prevalence, prompting advice for symptomatic individuals to stay home and avoid contact with vulnerable people.